CSIR NET Ch 4A

  • Upload
    manchow

  • View
    218

  • Download
    0

Embed Size (px)

Citation preview

  • 8/2/2019 CSIR NET Ch 4A

    1/4

    *MUDRA* Life Sciences For NET & SET Exams. Of UGC-CSIR

    ______________________________________________________________________________

    Section B & C Vol-06

    1

    Section B and C

    Volume-06

    Contents

    4. CELL COMMUNICATION AND CELL SIGNALING

    A. HOST PARASITE INTERACTION 1

    B. CELL SIGNALING 19

    C. CELLULAR COMMUNICATION 69

    D. CANCER 101

  • 8/2/2019 CSIR NET Ch 4A

    2/4

    *MUDRA* Life Sciences For NET & SET Exams. Of UGC-CSIR

    ______________________________________________________________________________

    Section B & C Vol-06

    2

    4. CELL COMMUNICATION AND CELL SIGNALING

    A. HOST PARASITE INTERACTION

    Mode of Transmission and alteration of host cell behavior by pathogens:

    Every infectious disease is transmitted to humans from its reservoir by a characteristic

    mode of transmission. The most common modes are

    (1) Ingestion of food or water contaminated by faeces (the oral-faecal route),

    (2) Contamination of the respiratory tract by droplets or other material containing

    respiratory secretions (the respiratory route), and

    (3) Direct contact with another person, animal, or contaminated object. Another

    important mode of transmission is inoculation through the skin when a wound is produced by an

    inanimate object or, by the bite of an arthropod or mammal.

    Bacterial pathogens

    One of the great, achievements of medical science, occurring in this century, was the

    discovery of therapeutically effective anti-bacterial drugs. Now, nearly all bacterial diseases can

    be cured if an accurate diagnosis is made early in the course of the infection. In the following

    discussions of the principal human bacterial diseases, emphasis is placed on features important in

    their recognition and control.

    TABLE:1. PATHOGENIC GRAM POSITIVE BACTERIA

    Group of Pathogenic bacteria Disease Caused

    Nocardioform bacteria

    Corynobacterium diphtheriaeMycobacterium bovis

    M. leprae

    M. tuberculosisNocardia anteroidea

    Endospore forming bacteria

    Bacillus anthracisClostridium botulinumC. diffelle

    C. perfringene

    C. tetani

    StaphilococciStaphilococcus aureus

    DiphtheriaTuberculosis

    Leprosy

    TuberculosisInfection in immunodeficient individuals

    AnthraxBotulism

    Pseudomembranus colitis

    Gangrene

    Tetanus

    Impedigo, boile, wound infections,

    pneumonia, toxic shock syndrome

  • 8/2/2019 CSIR NET Ch 4A

    3/4

    *MUDRA* Life Sciences For NET & SET Exams. Of UGC-CSIR

    ______________________________________________________________________________

    Section B & C Vol-06

    3

    Staphylococcal Diseases

    Nearly all human staphylococcal diseases are caused by Staphylococcus aureus, a

    facultatively anaerobic coccus that produces clumps of cells as it grows. It occurs on the skin and

    nasal passages of healthy humans and domestic animals. Approximately, 50 percent of these

    strains produce a heat-stable enterotoxin that causes food poisoning when ingested. S. aureus can

    also cause a wide variety of infections that are described as pyogenic (pus-forming). Examples

    include impetigo, boils, wound abscesses, and pneumonia. Impetigo is a superficial skin

    infection that is common in children and occasionally occurs in adults; boils (furuncles) are

    abscesses that form in hair follicles.

    Pathogenic staphylococci produce a number of extra-cellular proteins that are important

    in pathogenesis, including coagulase, leukocidin, and haemolysin. Coagulase initiates formation

    of blood clots that can protect bacteria from phagocytosis. Leukocidins are cytotoxins that kill

    leukocytes; haemolysins are cytotoxins that lyses red blood cells in vitro and are also toxic to

    leukocytes.

    Streptococcal Diseases

    Two species of streptococci, S. pyogencs and S. pneumoniae, cause most human

    streptococcal disease. The human population is the reservoir of these two species of facultatively

    anaerobic cocci that grow in chains. S. pneumoniae, commonly calledpneumococcus, is present

    in the upper respiratory tract of most healthy individuals, but S. pyogenes is rarely present in

    healthy people.

    The most important pneumococcal diseases are pneumonia, otitis media (infection of the

    middle car), and meningitis (infection of the membranes surrounding the brain). Immunity

    depends on production of an antibody that binds specifically to pneumococcal polysaccharide.

    The most common diseases caused by S. pyogenes are impetigo (which is similar in

    appearance to the impetigo caused by Staphylococcus aureus), and streptococcal pharyngitis

    (streptococcal sore-throat). Many strains ofS. pyogenesproduce, both extracellular enzymes that

    break down host macromolecules and streptoldnases, enzymes that activate a host factor that

    dissolves blood clots. It has been suggested, but not proven, that these enzymes facilitate the

    spread of streptococci. Most strains also produce the cytotoxins, streptolysin and streptolysin S

    that kill host leukocytes and red blood cells, thereby contributing to the pus formation,

  • 8/2/2019 CSIR NET Ch 4A

    4/4

    *MUDRA* Life Sciences For NET & SET Exams. Of UGC-CSIR

    ______________________________________________________________________________

    Section B & C Vol-06

    4

    characteristic of streptococcal disease. Strains that secrete these streptolysins can be readily

    identified; because, they produce clear zones of lysis, termed -haemolysis, when grown on

    blood agar. Some other streptococci produce, by an unknown mechanism, small zones of partial

    haemolysis, termed -haemolysis. Some strains secrete also a toxin termed erythrogenic toxin

    that produces the characteristic rash of scarlet fever. There are three distinct types of

    erythrogenic toxin, and the gene encoding each is carried on the chromosome of a temperate

    bacteriophage. Immunity to S. pyogenes depends on antibodies that bind to a protein, termed M

    protein, that is located on the cell surface and that inhibits phagocytosis. There are more than 50

    antigenically distinct types of M protein, and immunity to one type docs not protect the host

    from infection by another.

    Streptococcal pharyngitis is, occasionally, followed by post-streptococcal glomerulo-

    nephritis, a disease characterized by temporary kidney failure, apparently caused by immune

    complexes (produced from fragments of streptococcal walls cross-linked by antibodies) that

    become lodged in the glomeruli of kidneys. Streptococcal pharyngitis can also be followed by

    rheumatic fever, a disease, characterized in part, by an enlargement of the heart and temporary

    arthritis. In turn, rheumatic fever m some cases is followed by a more serious disease, rheumatic

    heart disease. Although it is clear that streptococcal infection plays a role in causing these two

    diseases, the mechanisms involved are not understood.

    Diseases caused by Endospore-Forming Bacteria

    The diseases caused by various endospore-forming bacteria. One of these, anthrax, which

    was studied by R. Koch, and by L. Pasteur, is primarily a disease of sheep. Rarely, it affects

    humans when spores of the causative agent, Bacillus anthracis, enter a wound or are inhaled. In

    the latter case, they cause a severe pneumonia termed woolsorters disease.

    Clostridial gangrene develops in necrotic (dead) tissue that has lost its blood supply. As a

    consequence, spores of certain obligate anaerobes, often Clostridium perfringens, can germinate

    and vegetative cells can proliferate there. As they do, they secrete hydrolytic enzymes and

    cytotoxins that kill and digest surrounding host cells, expanding the necrotic area in which the

    clostridial cells grow. Antibiotics are of little use in the treatment of gangrene; because, without

    a blood supply in the affected tissue, there is no effective way to get them into the site of

    infection.